Electrophoresis Market

Electrophoresis Market Size (2023 to 2028)

The size of the global electrophoresis market is estimated to be worth USD 3.26 billion by 2028 from USD 2.5 billion in 2023, growing at a CAGR of 5.4% from 2023 to 2028. 

Electrophoresis Market Share Insights:

• Based on product, the reagents segment accounted for the leading share of the global market in 2022.
• Based on application, the domestic segment had the major share of the worldwide market in 2022.
• Based on end-user, the hospitals and diagnostic centers segment held the largest share of the global market in 2022.
• Based on region, North America led the market in 2022.

MARKET DRIVERS:

The growing investments from governmental organizations for the R&D of proteomics and genomics in electrophoresis majorly drive market growth. Governments around the world have been investing heavily in R&D in the field of proteomics and genomics, and this is the driving demand for electrophoresis. The rise in affordability of electrophoresis equipment and reagents boosts market growth. For instance, significant government investment in research and development is driving market expansion in China and India. The rising demand for personalized treatment in the U.S. is contributing to the market growth. Electrophoresis is a reliable and affordable technique that is well-suited for rapid and accurate testing.

The rapid adoption and increasing demand for personalized medicine further fuel the growth rate of the electrophoresis market. Personalized medicine is a new way of healthcare that tailors treatment to the individual patient. Electrophoresis is a key tool for personalized medicine, as it can be used to identify genetic mutations that are linked with disease. The growing patient population suffering from chronic diseases promotes market growth. The incidence of chronic diseases such as cancer, diabetes, and heart disease is rising worldwide. Electrophoresis is a valuable tool for diagnosing these diseases.

The emergence of the latest technologies, the launch of innovative devices, the rising demand for genomics applications and increasing investments in research centers drive the market growth. The growing tendency for artificial chromosome libraries and even demands for genetic mapping support the market growth. The growing support from the government to develop quality treatment procedures, the rising prevalence of the analysis of vaccines and drugs in the pharmaceutical industry, increasing prevalence of chronic diseases like infectious diseases, cancer, and genetic disorders drives the global electrophoresis market. The growing usage of Next Level Sequencing (NGS) and increased capillary electrophoresis with mass spectroscopy propel the market growth. Moreover, many industries and academic research institutes collaborate and integrate innovations in biochemical, molecular, and biological research to develop an effective treatment, fueling the market. Further, the increase in the Prominence of Nanoproteomics is another factor demanding market growth.

The increase in the usage of Electrophoresis techniques in emerging countries like China, India, etc., is expected to boost the market in coming years. The rise in the number of clinical, forensic, and research laboratories boosts the market. Moreover, the move from plant-derived to genome-based drug discovery is estimated to propel the market. The increasing demand for personalized medicine is a significant opportunity for the Electrophoresis Market.

MARKET RESTRAINTS:

The high cost associated with the instruments and reagents restrains the market growth. The presence of alternative technologies providing better efficiency and results hinders the electrophoresis market growth. Moreover, the limited sample analysis and time-taking operations are hammering the market. Heavy usage of hazardous chemicals used with electrophoresis may affect the patient, available on Electrophoresis Instruments. So, Safety is the only and significant challenge for the electrophoresis market.

Impact of COVID-19 on the global electrophoresis market:

The COVID-19 pandemic has had a significant impact on the market for electrophoresis. Electrophoresis is a technique used to separate and identify DNA, RNA, and proteins. As it enables the detection of the SARS-CoV-2 virus, it is a crucial step in the diagnosis of COVID-19. Electrophoresis was mostly employed in research settings before the pandemic. It is now more frequently used in clinical settings due to the demand for quick and precise COVID-19 testing. As a result, there is an increase in demand for electrophoresis tools and supplies. Another reason why electrophoresis has become more widely used for COVID-19 diagnosis is the development of a set of primers for evaluating binding created by the Centers for Disease Control and Prevention (C     DC) and approved by the World Health Organization (WHO) for routine PCR diagnosis of COVID-19. With the help of these primers, particular areas of the SARS-CoV-2 genome can be amplified and subsequently electrophoretically detected. It is a good alternative for point-of-care testing because it is a relatively cheap and easy-to-comprehend procedure. This is essential in COVID-19 since it enables quick patient testing at medical facilities. In the upcoming years, electrophoresis will probably still be used more frequently to diagnose COVID-19. As the pandemic demonstrated, quick and precise testing will be required to locate and segregate affected people. Electrophoresis is a well-established and reliable technique that is well-suited for this task.

REPORT COVERAGE:

This research report on the global electrophoresis market has been segmented and sub-segmented into the following categories.

Electrophoresis Market - By Product:

• Gel Electrophoresis
  • Horizontal
  • Vertical
• Capillary Electrophoresis
• Reagents
• Geldoc
• Imaging

Based on product, the reagents segment is expected to account for the major share of the global market and grow at a CAGR of 6.13% during the forecast period. Reagents are essential components used in electrophoresis experiments. The continuous demand for reagents, including buffers, stains, and dyes for efficient and accurate results and increasing advancements in reagent formulations, such as DNA and protein stains with higher sensitivity and compatibility drive the growth of the reagents segment in the global market. The rising emphasis on optimizing reagents for specific applications and reducing potential hazards and consistent demand due to routine laboratory usage and consumable nature further contribute to the growth rate of the reagents segment.

The gel electrophoresis segment is expected to grow at a faster CAGR during the forecast period. Gel electrophoresis is a widely adopted technique for separating and analyzing biomolecules. Versatile applications of gel electrophoresis in various fields, including genomics, proteomics, and molecular biology research and the availability of a wide range of gel types, such as agarose and polyacrylamide gels, catering to different research needs to drive the growth of the gel electrophoresis segment.

Electrophoresis Market - By Application:

• Diagnostic
• Research
• Quality Control

Based on the application, the diagnostic segment is expected to hold the leading share of the global market during the forecast period. Factors such as the growing demand for accurate and efficient diagnostic methods in healthcare settings, rising prevalence of genetic and metabolic disorders requiring effective diagnostic tools and the rapid adoption of electrophoresis techniques for hemoglobinopathies and protein analysis propel the growth of the diagnostics segment in the global market. The expansion of point-of-care testing and the need for rapid and reliable diagnostic solutions, advances in electrophoresis technology, such as capillary electrophoresis and growing awareness among healthcare professionals about the benefits of electrophoresis in diagnostics further support the growth of the diagnostics segment.

The research segment is estimated to grow at the fastest CAGR during the forecast period due to its widening application of electrophoresis in drug discovery. Continuous advancements in genomics and proteomics research that create a demand for precise separation and analysis of biomolecules drive the growth of the research segment. The rising focus on personalized medicine and biomarker discovery, driving the need for sophisticated electrophoresis techniques, increasing funding and grants for research projects involving electrophoresis and the expansion of academic and industrial research collaborations that promote the utilization of electrophoresis in various fields fuel the growth rate of the research segment in the global market.

Electrophoresis Market - By End Users:

• Academic and Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers

Based on end-users, the hospitals and diagnostic centers segment is predicted to hold a leading share of the global market during the forecast period. The growing utilization of electrophoresis for clinical diagnostics, such as the analysis of hemoglobinopathies and serum protein abnormalities and rising demand for electrophoresis-based tests for disease diagnosis and monitoring in healthcare settings majorly drive the segmental growth. The academic and research institutes segment is expected to grow the fastest CAGR during the forecast period. The growing adoption of electrophoresis in molecular biology research and genetic studies and application of electrophoresis techniques in various disciplines, including biochemistry, microbiology, and genetics further boost the growth rate of the academic and research institutes segment in the worldwide market.

Electrophoresis Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, North America accounted for the largest share of the global electrophoresis market in 2022 and the domination of the regional market is expected to continue throughout the forecast period owing to the growing disposable income among the people in North America. Also, the quick adoption of advanced technology is making the market move forward. The increase in innovation in electrophoresis techniques, the rise of private and government funding for research on proteins and genes, and the presence of key market players drive the North American electrophoresis market. 

The Asia Pacific is positioned second in leading the highest shares of the market with the rising geriatric population. The market is expected to grow at a CAGR of 6.72% during the forecast period. The growing investments in pharmaceutical and biotechnology companies, the rise in awareness about personalized therapeutics, the low cost of manufacturing, and increasing research activities in mAbs-based therapeutics are driving the Asia Pacific electrophoresis market.

Europe has been growing faster in past years and is expected to continue the same flow in the near future. The UK electrophoresis market holds the highest shares owing to constant economic growth over the past few years. Germany's electrophoresis market is positioned second due to the development of new products with advanced technologies.

Latin America, and Middle East & Africa are expected to have significant growth opportunities in the coming years.

KEY MARKET PARTICIPANTS:

Some of the notable players dominating the global electrophoresis market profiled in the report are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Serbia Group, and C.B.S. Scientific Company.

RECENT HAPPENINGS IN THE MARKET:

• In 2023, Medispec (India) was signed by Advanced Electrophoresis Solutions Ltd (Canada) as the exclusive distributor partner. Through this partnership, AES' critical solutions will be made accessible to numerous companies based in India.
• In 2022, ThermoFisher Scientific introduced the Applied Biosystems SeqStudio Flex Series Genetic Analyzer, aiming to empower customers' groundbreaking research in fields like gene editing and infectious disease.
• In 2020, Danaher Corp. completed the acquisition of GE Healthcare Life Sciences, which was subsequently rebranded as Cytiva. This transformative move has resulted in the formation of a $3.3 billion global life sciences company, employing nearly 7000 individuals across 40 countries.